Aspergillus fumigatus ( Afu ) is an important fungal pathogen causing allergic and invasive respiratory disorders. A plethora of multi-functional allergens/antigens secreted by Afu have been implicated in pathogenesis. The present study was undertaken to identify and characterize novel Afu allergen/antigen by cDNA library approach. cDNA library of Afu was immunoscreened with pooled sera of allergic bronchopulmonary aspergillosis (ABPA) patients. The cDNA clone, TS1, reacting significantly with specific IgG antibodies, was selected. cDNA was subcloned and expressed in Escherichia coli. Sequencing of the cDNA revealed an open reading frame (ORF) of 1179 bases coding for a protein with an approximate molecular weight of 44 kDa. Immunoreactivity of the recombinant TS1 protein (rTS1) was evaluated by ELISA and Western blot analysis using pooled sera of ABPA patients. The rTS1 exhibited binding to specific IgG and IgE antibodies present in sera of ABPA patients. The deduced amino acid sequence showed homology to 60S ribosomal protein L3 (RpL3) of Aspergillus nidulans , Saccharomyces cerevisiae and Homo sapiens . The RpL3 of S. cerevesiae, tcm1 , to which TS1 sequence shows significant homology (72% identity), is known to be responsible for conferring resistance against trichodermin (antibiotic, inhibiting protein synthesis). The present study has led to identification, cloning and expression of a 44-kDa novel allergen/antigen of Afu with sequence homology to L3 ribosomal protein with a probable role in resistance of Afu to antifungal drugs. Sixty-four per cent sequence identity of Afu RpL3 with human RpL3 and common regions in their predicted epitopes suggest a possibility of involvement of Afu RpL3 in autoimmune reactions due to molecular mimicry.
INTRODUCTION
Aspergillus fumigatus ( Afu ), a ubiquitous mould, is an opportunistic pathogen associated with allergic and invasive aspergillosis [1] . This pathogenic fungus secretes several virulence factors which facilitate crossing of epithelial barriers, leading to disease development [2] . A number of multi-functional allergens/antigens secreted by Afu also contribute to pathogenicity [3] .
Elevated serum levels of IgG and IgE antibodies against allergens/antigens of Afu are used as an important diagnostic criteria in Afu -induced allergic disorders [4] . A major problem in the diagnosis of Afu -induced allergic disorders arises from the lack of standardized diagnostic reagents. Commercial Afu extracts show variable allergenicity owing to the differences in the strain used, growth conditions, harvesting and extraction procedures [5] . Although the extracts of Afu are known to contain approximately 200 different proteins, glycoproteins and low molecular weight compounds, the current update of Afu allergens by the International Union of Immunological Societies (WHO/IUIS, http:// www.allergen.org/List.html) lists only 19 allergens from Afu [6] .
Introduction of the molecular biology approaches such as the cDNA library has allowed cloning, characterization and production of large amounts of single and highly pure Afu allergens in a rapid manner [7, 8] . Screening of cDNA libraries with patient sera leads to identification of several previously undescribed allergens in virtually a single experiment. Positive clones are sequenced and compared to known sequences in the electronic databank. Identification and characterization of various allergens/antigens of Afu would contribute substantially to understanding of pathogenesis and biology of the fungus. Such studies would also facilitate development of novel effective therapeutic strategies, in view of the serious limitations of the currently available antifungal therapies, such as toxicity and development of drug-resistant strains.
The present study describes the molecular cloning and expression of a novel 44-kDa immunoreactive protein from the Afu cDNA library. The deduced amino acid sequence of the cDNA shows homology with L3 ribosomal protein (RpL3), a component of 60S ribosomal subunit, from different organisms, including H. sapiens . This protein is an important component of peptidyl transferase centre of the ribosome and has also been involved in conferring resistance to protein synthesis inhibiting drugs such as trichodermin in S. cerevisiae .
MATERIALS AND METHODS

Materials
Serum samples of allergic bronchopulmonary aspergillosis (ABPA) patients ( n = 30) (following Rosenberg's criteria) and normal subjects ( n = 10) were obtained from Vallabhbhai Patel Chest Institute, Delhi as per the guidelines of the institutional human ethics committee [9] . The parameters taken into account for the selection ABPA patients are: asthma, peripheral blood eosinophilia ( > 1·0 ¥ 10 9 /l), immediate cutaneous reactivity to Afu antigen, precipitating antibodies against Afu antigen, elevated total serum IgE ( > 1000 ng/ml), chest X-ray infiltrates (or history of), transient or fixed proximal bronchiectasis, elevated serum IgE and IgG antibodies (specific to Afu antigen).
Restriction enzymes and ligase were purchased from New England Biolabs (Beverley, MA, USA). Polymerase chain reaction (PCR) was performed using the thermal cycler from Perkin Elmer Cetus. DNA amplification reagents were purchased from Bangalore Genei (Bangalore, India). GFX TM DNA and gel band purification kit for purification of PCR products was obtained from Amersham Pharmacia Biotech Inc. (Piscataway, NJ, USA). Nitrocellulose membranes were purchased from Schleicher and Schuell (Keene, NH, USA). Peroxidase conjugated antihuman IgG and antihuman IgE antibodies were obtained from Sigma (St Louis, MO, USA).
cDNA library Afu cDNA library constructed in Uni-ZAP XR lambda vector was obtained from Stratagene (La Jolla, CA, USA). Escherichia coli strains XL-1 Blue MRF ¢ and SOLR (Stratagene, La Jolla, CA, USA) were used for recombinant DNA manipulations. The cDNA library was amplified using the manufacturer's instructions.
Antibody screening of cDNA library and selection of clone Immunoscreening of a l ZAP cDNA library was performed under standard conditions [10] . Briefly, E. coli XL-1 blue were infected with 6 ¥ 10 8 phages containing cDNAs and plated onto NZY-agar plates. Expression of fusion protein was induced by overlapping nitrocellulose filters impregnated with 10 m M isopropyl-beta-Dthiogalactopyranoside (IPTG) and followed by incubation of the plates for 4 h at 42 ∞ C. The plates were incubated further at 37 ∞ C for another 4 h. Filters were washed first with Tris-buffer saline (TBS) (10 m M Tris, pH 8·0, 150 m M NaCl, TBS) with 0·05% v/v Tween 20. They were then blocked with 3% skimmed milk powder in TBS at 37 ∞ C for 1 h and were incubated overnight with pooled sera of ABPA patients ( n = 10) (preabsorbed against E. coli proteins and diluted 1 : 100 in TBS). Filters were washed in TBS containing 0·05% (v/v) Tween 20 (TBST), and reacted with HRP conjugated antihuman IgG (diluted 1 : 1000 in TBS). Membranes were given a final wash in TBST and were developed with 3,3 ¢ diaminobenzidine tetrahydrochloride and 0·3% v/v hydrogen peroxide. TS1 was one of the positive clones. Selected plaque was rescreened, purified to homogeneity and corresponding pBluescript SK ( + /-) phagemid was rescued by in vivo excision using ExAssist helper phage. The E. coli SOLR cells were infected with the phagemid and were plated onto LB-ampicillin (50 m g/ml) agar plates and incubated at 37 ∞ C overnight. Colonies appearing on the plate containing the pBluescript double-stranded phagemid having the cloned DNA insert was used for colony PCR using T3 (5 ¢ AAT TAA CCC TCA CTA AAG GG-3 ¢ ) and T7 (5 ¢ CGG GAT ATC ACT CAG CAT AAT G-3 ¢ ) primers. PCR cycling conditions were 94 ∞ C/4 ¢ and 28 cycles of 94 ∞ C/1 ¢ , 58 ∞ C/1·5 ¢ , 72 ∞ C/2 ¢ followed by a terminal extension cycle at 72 ∞ C/7 ¢ .
Sequence analysis of TS1
The PCR product thus obtained was sequenced using T3, T7 and two internal primers, Int 1 (5 ¢ -GAC AGT ATC TTC GAG AAG GAC GA-3 ¢ ) and Int 2 (5 ¢ -CGC AAC CTG TTC GAG AAG CCC ATT-3 ¢ ). Automated DNA sequencing and oligonucleotide synthesis was performed by sequencing facility at the Institute of Genomics and Integrative Biology, using ABI-3100 DNA sequencer (Applied Biosystems). The deduced amino acid sequence was determined using the Translate Tool software in the Expasy Molecular Biology Server (http://www.expasy.com). The deduced amino acid sequence was submitted to the database of National Center for Biotechnology Information (NCBI) using the Basic Local Alignment Search Tool ( BLAST ) server for nucleotide and amino acid homology searches (http://www.ncbi.nlm.nih.gov/ BLAST).
Subcloning, expression and purification of rTS1
The cDNA insert was amplified using the modified forward primer (5 ¢ -AGC GAC AAC AGG AAT TCG ATG AGT CAC CGG AAG TAC-3 ¢ , carrying an Eco RI site) and T7 as reverse primer. The amplified product was digested with Eco RI and Xho I, and the resulting fragment was inserted into pGEX-5X-3 expression vector, which was digested previously with the same restriction enzymes. The resulting plasmid was designated as pGEX-TS1. E. coli strain BL21 was transformed with plasmid pGEX-TS1 following the standard method [11] . The transformed cells were grown in 2 YT medium containing 100 m g/ml ampicillin at 37 ∞ C until the OD 600 reached 0·5. IPTG was then added to a final concentration of 0·5 m M , and the culture was grown for an additional 5 h at 37 ∞ C with shaking. Cells were harvested by centrifugation at 5000 g for 15 min and resuspended in 20 ml sonication buffer (50 m M Tris/HCl pH 7·4, 150 m M NaCl, 1 m M EDTA, 10% (v/v) glycerol, 1 m M PMSF and 10 m g/ml aprotinin). The cells were sonicated on ice for 2 min, and sonicate was supplemented with Triton X-100 to a final concentration of 1% before centrifugation at 30 000 g for 30 min at 4 ∞ C. The supernatant was incubated overnight at 4 ∞ C with glutathione-Sepharose 4B matrix (Pharmacia Biotech). The resin bound to protein was packed into a column and washed with five bed volumes of phosphate-buffered saline (PBS) (1·44 g disodium hydrogen phosphate, 0·24 g potassium dihydrogen orthophosphate, 0·2 g potassium chloride, 8·0 g sodium chloride in 1 l distilled water, pH 7·2, PBS). Fractions containing purified rTS1 protein were pooled and the purity of the recombinant protein was confirmed on 10% SDS-PAGE.
Immunoblotting of recombinant protein with pooled sera of ABPA patients For immunoblot analysis, rTS1 was separated by 10% SDS-PAGE and transferred to nitrocellulose membrane at constant current of 100 mA for 4 h in Bio-Rad mini Trans-blot cell. The nitrocellulose membrane was blocked with 3% non-fat milk in PBS at 37 ∞ C for 1 h followed by washing. The membrane strips were incubated at 4 ∞ C overnight with 1 : 100 v/v dilution (for IgG
Immunodot-blot
The allergenicity of rTS1 was determined in vitro by dot-blot immunoassay using a panel of sera from 30 ABPA patients following standard protocol [13] . Briefly, 1 mg of rTS1 fusion protein was applied onto Hybond C nitrocellulose membrane (Amersham Life sciences, UK). Five mg of Afu 3-week culture filtrate (3 wcf) was used as positive control while 1 mg of purified glutathione-S-transferase (GST) was used as a negative control (because culture filtrate is a mixture of number of allergens/antigens, five times more quantity was used than the purified proteins). Dot blots were blocked with 5% non-fat milk powder in PBST (PBS with 0·05% Tween 20). The blots were incubated separately with 1 : 50 (v/v) dilution of sera of 30 ABPA patients for 3 h at 37∞C. After three washes with PBST, the blots were incubated with peroxidase conjugated antihuman IgE (1 : 1000 v/v) for 1 h at 37∞C. A similar washing procedure was followed and the blots were developed with substrate, 3,3¢ diaminobenzidine tetrahydrochloride and 0·3% v/v hydrogen peroxide. All reactions with visible dots (compared to positive control dots) were scored as positive. The enzyme reaction was stopped by rinsing with deionized water.
Identification of epitopic regions
The DNASTAR module of the Lasergene software package was used for computational analysis of deduced amino acid sequence. Various algorithmic programs were used, such as the Chou-Fasman algorithm (prediction of secondary structure), the HoppWoods method (protein antigenic determinants), the Kyte and Doolittle method (regional hydropathy of protein) and Jameson Wolf's method for antigen index and identification of probable epitopic regions [14] .
RESULTS
PCR and sequence analysis of the cDNA clone, TS1
Sequencing of the cDNA insert using T3, T7, Int1 and Int2 revealed an ORF of 1179 base pairs coding for 392 amino acids.
The cDNA has a complete 3¢ untranslated region with a poly A tail. A polyadenylation signal, AATAAA, was present 18 base pairs upstream of the poly A tail. The sequence of TS1 cDNA was submitted to the NCBI GenBank (Accession number: BankIt439468, AF464911).
BLASTX homology search results showed that the deduced amino acid sequence shares significant homology with L3 ribosomal proteins of different organisms (Fig. 1) (Fig. 1) .
Characterization of purified rTS1
The purified rTS1, expressed as GST fusion protein, resulted in a single band on denaturing 10% SDS-PAGE (Fig. 2 a) . The predicted size of GST-TS1 was 73 kDa (44 kDa for TS1 protein and 29 kDa for the attached GST protein).
Immunoreactivity of rTS1
rTS1 showed reactivity with IgE and IgG antibodies in the pooled sera of ABPA patients on Western blot (Fig. 2b) . The ELISA absorbance value of rTS1-specific IgG antibodies in pooled sera of ABPA patients was 5 fold higher than the controls ( Table 1) . The ELISA absorbance value of rTS1-specific IgE antibodies in pooled sera of ABPA patients was 6·4-fold higher than the controls (Table 1 ). In the dot-blot analysis, seven of 30 ABPA patients (26·7%) showed presence of IgE antibodies against rTS1 (Fig. 3) . All the 30 sera showed presence of specific IgE antibodies against 3 wcf of Afu. Because rTS1 was expressed as a fusion protein with GST, purified GST alone was used as a negative control to rule out non-specific reaction of ABPA sera with GST. None of the 30 sera reacted with GST.
Prediction of antigenic index and epitopic analysis
The deduced amino acid sequence of TS1 was analysed for the prediction of potential antigenic determinants by using the PRO-TEAN module of LASERGENE. This analysis predicted several potential antigenic sites and 11 regions were observed to have a high antigenic index ( Table 2) . Pooled ABPA patients sera 0·624 ± 0·050 0·256 ± 0·021 Normal human sera 0·124 ± 0·054 0·040 ± 0·034
All the readings are mean values representing three readings for each sample. 
DISCUSSION
The current study, involving immunoscreening of the cDNA library of Afu, led to identification and expression of a 44-kDa protein with sequence homology to L3 ribosomal proteins. Significantly higher levels of specific IgG and IgE antibodies to the purified protein observed in sera of ABPA patients than controls suggested that it may be a novel allergen/antigen of Afu. Although other ribosomal proteins such as P2, L7 and L12 have been found to be allergenic/antigenic in Afu, Cladosporium herbarum and Brucella melitensis, none of the RpL3s has been proposed as an allergen/antigen until now [15] [16] [17] . The presence of IgE antibodies to rTS1 in 26·7% of the ABPA patients indicated that it may be a minor allergen of Afu according to the allergen nomenclature guidelines given by the IUIS (IUIS, allergen nomenclature subcommittee, http://www.allergen.org/Editoral. html).
Multiple sequence alignment using the sequences of RpL3 from Afu, A. nidulans, S. cerevisiae and H. sapiens showed that this protein belongs to the category of highly conserved proteins. RpL3 is vital for the function of the ribosome and has been shown to participate in or initiate the early steps of the ribosomal assembly, where it binds with high affinity to the 23S rRNA [18, 19] . It is involved in the formation of the peptidyltransferase centre and is essential for its catalytic activity [20] [21] [22] [23] . The L3-binding site has been localized to a long double helix, containing a large internal loop and a sarcin/ricin loop in domain VI of 23S rRNA [24, 25] .
The deduced amino acid sequence showed significant homology to tcm1, which encodes RpL3 of S. cerevisiae. It is interesting to note that tcm1 has been implicated in resistance of S. cerevisiae to trichodermin (an inhibitor of ribosome peptidyl transferase activity) [26, 27] . Although many strains of Afu have been shown to be resistant to antibiotics, only limited information is yet available regarding the genes conferring antibiotic resistance to Afu. However, recently Afu ribosomal stalk proteins such as P0 phosphoprotein has been implicated in resistance to sordarin antifungals [28] . On the basis of significant sequence homology to tcm1, the RpL3 of Afu could be implicated in antibiotic resistance of Afu, although this requires experimental confirmation. Sixty-four per cent sequence identity of Afu RpL3 with human RpL3 and common regions in their predicted epitopes suggests the possibility of involvement of Afu RpL3 in autoimmune reactions. There are reports of the involvement of phylogenetically conserved proteins of Afu in autoimmune reactions in patients of aspergillosis, such as Asp f6 (manganese superoxide dismutase), Asp f8 (P2 acidic ribosomal protein) and Asp f11 (cyclophilin) (sequence identity of >50% with the corresponding human protein) [15, 29, 30] . In a previous study, significantly high levels of specific IgG and IgE antibodies to human fibronectin and collagen type IV were observed in sera of ABPA patients, suggesting the role of autoimmune reactions in immunopathogenesis of aspergillosis [3] . Tissue damage due to the inflammatory process observed in patients of aspergillosis might result in release of autoantigens [31] . Exposure to autoantigens containing cross-reactive determinants (molecular mimicry) can result in an autoimmune response by recruiting the memory T cell repertoire at the site of inflammation.
In conclusion, the present study has led to identification of a novel allergen/antigen of Afu with sequence homology to L3 ribosomal protein, which may be involved in autoimmune reactions in patients of aspergillosis and in conferring drug resistance to Afu.
